A patient has symptomatic heart failure with preserved ejection fraction, eGFR 54 mL/min/1.73 m² and potassium 4.2 mmol/L. Which disease-modifying

Question

A patient has symptomatic heart failure with preserved ejection fraction, eGFR 54 mL/min/1.73 m² and potassium 4.2 mmol/L. Which disease-modifying combination is now considered by NICE?

Accepted Answer

A mineralocorticoid-receptor antagonist plus an SGLT2 inhibitor

Answer

A loop diuretic plus long-term oral nitrate monotherapy

Answer

An ACE inhibitor plus a non-dihydropyridine calcium-channel blocker

Answer

A cardiac glycoside plus a thiazide-like diuretic

Answer

A beta-blocker plus a class-I antiarrhythmic medicine

Heart failure optimisation — GPhC CRA MCQ

A patient has symptomatic heart failure with preserved ejection fraction, eGFR 54 mL/min/1.73 m² and potassium 4.2 mmol/L. Which disease-modifying combination is now considered by NICE?